RESEARCH PAPER
Cytomegalovirus pneumonia in HIV-infected patients: case series from Iran
 
More details
Hide details
1
Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Iran
 
2
Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Iran
 
3
Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Iran
 
 
Submission date: 2020-05-31
 
 
Final revision date: 2022-01-16
 
 
Acceptance date: 2022-02-11
 
 
Publication date: 2022-09-13
 
 
HIV & AIDS Review 2022;21(4):327-331
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Cytomegalovirus (CMV) is a leading cause of morbidity and mortality among the immunosuppressed population, and it is a common cause of opportunistic infections in human immunodeficiency virus (HIV)-positive patients. In this case series study, we describe our experience with nine HIV-positive patients suffering from pneumonia who demonstrated typical cyto-pathologic evidences of CMV pneumonitis.

Material and methods:
Clinical records of all HIV-infected patients with pneumonia who were admitted to National Research Institute of Tuberculosis and Lung Diseases (NRITLD), a tertiary center of tuberculosis and lung diseases in Iran, were prospectively reviewed. Results of micro-biological investigations of bronchoalveolar fluid (BAL) and trans-bronchial lung biopsy (TBLB) specimens were evaluated as well as their histological and cytological findings. All patients with cyto-pathologic evidences of CMV pneumonitis found in TBLB were extracted, characteristic of which was shown as enlarged cells with large pleomorphic nuclei, and intra-nuclear and cytoplasmic inclusions.

Results:
Of these cases, seven patients were diagnosed with concomitant CMV and Pneumocystis jiroveci pneumonitis. Five patients had thrush, two patients tested positive for active tuberculosis, and one patient reported a history of old tuberculosis. Laboratory data analysis revealed LDH ranging from 138 to 1,140, with average amount of 653.22. CD4+ counts ranged from 12 to 156, with average of 56.22. Six patients tested positive for CMV infection with plasma polymerase chain reaction (PCR) method.

Conclusions:
The differential diagnosis for CMV pneumonia in HIV-infected population is extensive and includes diseases, such as bacterial pneumonias, Mycobacterium tuberculosis infections, PCP, and other HIV-associated respiratory infections. Definitive diagnosis is based upon demonstration of CMV in pulmonary secretions or in lung tissue.

 
REFERENCES (34)
1.
Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA. Cytomegalovirus as a primary pulmonary pathogen in AIDS. Chest 1997; 111: 128-134.
 
2.
Millar AB, Patou G, Miller RF, et al. Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger? Am Rev Respir Dis 1990; 141: 1474-1477.
 
3.
Rodriguez-Barradas MC, Stool E, Musher DM, et al. Diagnosing and treating CMV pneumonia in patients with AIDS. Clin Infect Dis 1996; 23: 76-81.
 
4.
Adland E, Klenerman P, Goulder P, Matthews PC. Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era. Front Microbiol 2015; 6: 1016.
 
5.
Benfield TL, Helweg-Larsen J, Bang D, Junge J, Lundgren JD. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest 2001; 119: 844-851.
 
6.
Lathey, JL, Spector, SA. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol 1991; 65: 6371-6375.
 
7.
Nelson MR, Erskine D, Hawkins DA, Gazzard BG. Treatment with corticosteroids – a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS 1993; 7: 375-378.
 
8.
Ho M. Cytomegalovirus. In: Mandell GL, Bennett JE, Dolin R (eds.). Mandell, Douglas, and Bennett’s Principles and Practices of Infectious Diseases, 4th ed. New York: Churchill Livingstone 1995, pp. 1351-1364.
 
9.
Herry I, Cadranel J, Antoine M, et al. Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS: a new clinical entity? Clin Infect Dis 1996; 22: 616-620.
 
10.
Ramesh K, Gandhi S, Rao V. Clinical profile of human immunodeficiency virus patients with opportunistic infections: a descriptive case series study. Int J Appl Basic Med Res 2015; 5: 119-123.
 
11.
Bozzette SA, Arcia J, Bartok AE, et al. Impact of Pneumocystis carinii and cytomegalovirus on the outcome of atypical pneumonia in advanced human immunodeficiency virus disease. J Infect Dis 1992; 165: 93-98.
 
12.
Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis 1988; 158: 449-456.
 
13.
Miles PR, Baughman RP, Linneman CC. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. Chest 1990; 97: 1072-1076.
 
14.
Centers for Disease Control and Prevention. HIV/AIDS surveillance supplemental report. Atlanta: Centers for Disease Control and Prevention; 2001.
 
15.
Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002; 34: 1098-1107.
 
16.
Phair J, Muñoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med 1990; 322: 161-165.
 
17.
Masur H, Kaplan JE, Holmes KK; U.S. Public Health Service; Infectious Diseases Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons – 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002; 137 (5 Pt 2): 435-478.
 
18.
Aviram G, Fishman JE, Sagar M. 8-Cavitary lung disease in AIDS: etiologies and correlation with immune status. AIDS Patient Care STDS 2001; 15: 353-361.
 
19.
Corbett EL, Blumberg L, Churchyard GJ, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999; 160: 15‐21.
 
20.
Huang L, Crothers K. HIV‐associated opportunistic pneumonias. Respirology 2009; 14: 474-485.
 
21.
Kalavathi GP, Sagar H, Ravikumar BV. Clinical profile of symptomatic HIV infections at a tertiary care hospital. Int J Adv Res Med 2019; 1: 45-47.
 
22.
Hirsch MS. Cytomegalovirus infection. In: Harrison’s Principles of Internal Medicine, 17th ed. Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds.). New York, McGraw-Hill Inc.; 2010, pp. 752-754.
 
23.
Lundberg BE, Davidson AJ, Burman WJ. Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure. AIDS 2000; 14: 2559-2566.
 
24.
Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004; 350: 2487-2498.
 
25.
Curtis JR, Yarnold PR, Schwartz DN, Weinstein RA, Bennett CL. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2000; 162 (2 Pt 1): 393-398.
 
26.
Gruden JF, Huang L, Turner J, et al. High resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol 1997; 169: 967-975.
 
27.
González-García J, Rubio García R, Antela López A, García Alcaide F. Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment. Enferm Infecc Microbiol Clin 1998; 16 Suppl 1: 36-44.
 
28.
Xiao J, Gao G, Li Y, et al. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China. PloS One 2013; 8: e75915.
 
29.
Bower M, Barton SE, Nelson MR, et al. The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia. AIDS 1990; 4: 317-320.
 
30.
Salomon N, Gomez T, Perlman DC, Laya L, Eber C, Mildvan D. Clinical features and outcomes of HIV-related cytomegalovirus pneumonia. AIDS 1997; 11: 319-324.
 
31.
DeLorenzo LJ, Huang CT, Maguire GP, Stone DJ. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987; 91: 323-327.
 
32.
Du CJ, Liu JY, Chen H, et al. Differences and similarities of high-resolution computed tomography features between pneumocystis pneumonia and cytomegalovirus pneumonia in AIDS patients. Infect Dis Poverty 2020; 9: 149.
 
33.
Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000–2010. J Infect Dis 2016; 214: 862-872.
 
34.
Bonnet F, Lewden C, May T, et al.; Mortalité 2000 Study Group. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis 2005; 37: 482-487.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top